MedTrace Logo

Cytokine Adsorption During Complex Cardiac Surgery: a Controlled Randomized Trial

NCT06512623 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 41

Last updated 2026-01-23

No results posted yet for this study

Summary

This prospective single-centre randomized controlled trial aims at evaluating the safety and efficacy of hemoadsorption with HA-380® during cardio-pulmonary bypass in 40 patients undergoing complex cardiac surgery.

Conditions

  • Post-cardiac Surgery
  • Inflammation
  • Organ Dysfunction Syndrome
  • Cardiac Disease
  • Cardio-Pulmonary Bypass

Interventions

DEVICE

Hemoadsoprtion

The hemoadsorption treatment will be performed during the entire duration of the CPB. Blood flow within the cartridge is standardized at 250 ml/min.

Sponsors & Collaborators

  • Centre Hospitalier Universitaire Vaudois

    lead OTHER

Principal Investigators

  • Antoine Schneider · CHUV Centre Hospitalier Universitaire Vaudois (CHUV)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-27
Primary Completion
2025-12-18
Completion
2026-01-12

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06512623 on ClinicalTrials.gov